Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Myriad Genetics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- −4 vs. Q4 2022
- Shares held
- 82.2M
- +1.71M (+2.1%) vs. Q4 2022
- Total value
- $1.91B
- +$742.0M (+63.5%) vs. Q4 2022
- New holders
- 23
- 61 more added
- Sold out
- 27
- 75 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 0 | $0 | 0.00% | −17,914−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −14,974−100.0% | Sold out |
| Kula Investments, LLC | 0 | $0 | 0.00% | −13,577−100.0% | Sold out |
| Integrated Investment Consultants, LLC | 0 | $0 | 0.00% | −12,712−100.0% | Sold out |
| Connable Office Inc | 0 | $0 | 0.00% | −12,627−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,300−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −11,284−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −7,072−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −5,636−100.0% | Sold out |
| Boston Partners | 0 | $0 | 0.00% | −37,838−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −3,041−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −1,138−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −973−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −843−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |